Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
The management of heparin‐induced thrombocytopenia
2006
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Heparin-induced thrombocytopenia (HIT)
2006
Distinct cellular functions mediated by different VLA integrin α subunit cytoplasmic domains
1992
Intravenous high-dose igg therapy induced alterations of spleen lymphocyte igm secretion and t cell subsets in patients with idiopathic thrombocytopenic purpura
1987
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis
1989
An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia
2019
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin
1999
Manipulating the Immune System with Immune Globulin
1992
The Staphylococcus aureus α-toxin channel complex and the effect of Ca2+ ions on its interaction with lipid layers
1992
An Immunoglobulin Switchlike Sequence Is Linked With Canine Narcolepsy
1994
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity
2017
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients
2003
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia
1996
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia
2017
Narcolepsy and immunity
1995
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
2003
Guillain–Barré Syndrome
2012 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura
2000
Imaging α-Hemolysin with Molecular Dynamics: Ionic Conductance, Osmotic Permeability, and the Electrostatic Potential Map
2005
Transfusion Medicine — Blood Transfusion
1999 Standout
Myasthenia Gravis
1994 Standout
Platelet‐reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia
1999
Risk factors for thrombosis in patients with immune mediated heparin‐induced thrombocytopenia
2002
Cytotoxic antibodies trigger inflammation through Fc receptors
1995
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome
2019
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study
2014
The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long‐term serologic findings, and clinical significance
1990
Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia
1993
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
2006 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Frequency of Heparin‐Induced Thrombocytopenia in Critical Care Patients
2003
Autoimmune heparin‐induced thrombocytopenia
2017
Adhesion receptors of the immune system
1990 StandoutNature
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Scalable molecular dynamics with NAMD
2005 Standout
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Characterization of autoantibodies against the platelet glycoprotein antigens llb/llla in childhood idiopathic thrombocytopenia purpura
1995
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
1999 Standout
International study to compare antigen‐specific methods used for the measurement of antiplatelet autoantibodies
1997
Neonatal thrombocytopenia and hidden maternal autoimmunity
1993
Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan
1992
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.
1994
Multiple Sclerosis
2000 Standout
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
Heparin-induced thrombocytopenia in hemodialysis patients
1996
Disseminated Intravascular Coagulation
1999 Standout
Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH
2016
Heparin-induced thrombocytopenia is rare in pregnancy
2001
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
1987 StandoutNature
The Regulation of Apoptosis by Microbial Pathogens
1999
Platelet autoantibodies in patients with chronic liver disease
1995
Parvovirus B19
2004 Standout
Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia
2015
Staphylococcus aureusInfections
1998 Standout
A dose of 75 μg/kg/d of i.v. anti‐D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura
2001
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site
1990 Standout
A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpura
1999
Gram-positive Organisms and Sepsis
1994
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
2019
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
LEUKOTACTIC FACTORS ELABORATED BY VIRUS-INFECTED TISSUES
1972 StandoutNobel
CYTOSTATIC ELIMINATION OF SYNGENEIC RAT TUMOR CELLS IN VITRO BY NONSPECIFICALLY ACTIVATED MACROPHAGES
1973
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4–heparin antibodies to platelets and the resultant platelet activation
2000
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
1999 StandoutScience
Characterization of individual polynucleotide molecules using a membrane channel
1996 Standout
Influence of membrane fluidity on the assembly of Staphylococcus aureus alpha-toxin, a channel-forming protein, in liposome membrane.
1992
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease
2003
Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS
1999
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
1994
Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder
2014
Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane Pore
1996 StandoutScience
The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia
1993
High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia
1999 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Quantum Dot-Based Multiplexed Fluorescence Resonance Energy Transfer
2005 StandoutNobel
High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin‐induced thrombocytopenia antibodies
2013
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Biologic effects of leukocytes present in transfused cellular blood products
1994
Diagnosis and Clinical Course of Autoimmune Neutropenia in Infancy: Analysis of 240 Cases
1998
Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
2005
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients
1997
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
1985
Alpha-toxin of Staphylococcus aureus
1991
Staphylococcus aureus alpha-toxin. Dual mechanism of binding to target cells.
1991
Chemotaxis of leucocytes
1968
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.
1989 StandoutNobel
Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin
2005
Application of fluorescence resonance energy transfer in the clinical laboratory: Routine and research
1998
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
1994
Histidine residues near the N terminus of staphylococcal alpha-toxin as reporters of regions that are critical for oligomerization and pore formation
1994
Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4
2013
Prospective evaluation of the clinical usefulness of an antigen- specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias
1996
An endotoxin-induced serum factor that causes necrosis of tumors.
1975 Standout
Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity
1996
Generation of Anti-Hirudin Antibodies in Heparin-Induced Thrombocytopenic Patients Treated With R-Hirudin
1999
COAGULATION DISORDERS IN CANCER
1996
Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura
1994
Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants
1993
First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA
1999
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia
1996
The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others.
1989
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Bee and Wasp Venoms
1972 StandoutScience
Low-Molecular-Weight Heparins
1997 Standout
Fate of therapy failures in adult idiopathic thrombocytopenic purpura
1980
Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
1987
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
HLA and Disease 1982 ‐ A Survey
1983
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura
1992
Long‐Term Follow‐Up Study of 168 Patients with Immune Thrombocytopenia. Implications for Therapy
1984
Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III
2000 StandoutNobel
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
1996
Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases
1995
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Mastzelldegranulierendes Peptid (MCD-Peptid) aus Bienengift: Isolierung, biochemische und pharmakologische Eigenschaften
1968
Direct detection of activated protein C in blood from human subjects
1992
The molecular immunology of human platelet proteins
1992
Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model
1994
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of C. Mueller‐Eckhardt being referenced
The Clinical Significance of Platelet‐Associated IgG: a Study on 298 Patients with Various Disorders
1980
Autoimmune hemolytic anemias
1972
IgG therapy in autoimmune haemolytic anaemia of warm type
1984
Treatment of idiopathic thrombocytic purpura in pregnancy by high-dose intravenous immunoglobulin
1983
Heparin-associated thrombocytopenia: Successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins
1992
Recent trends in platelet antigen/antibody detection
1989
NA gene frequencies in the German population, determined by polymerase chain reaction with sequence‐specific primers
1995
Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia
1992
Alloimmune neonatal neutropenia is a potential side effect of immunization with leukocytes in women with recurrent spontaneous abortions
1992
Pregnancy complicated by heparin associated thrombocytopenia: Management by a prospectively in vitro selected heparinoid (ORG 10172)
1993
High-dose IgG treatment for neonatal alloimmune thrombocytopenia
1989
Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia
1996
348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
1989
Competitive Enzyme‐Linked Immunoassay for the Quantitation of Platelet‐Associated Immunoglobulins (IgG, IgM, IgA) and Complement (C3c, C3d) with Polyclonal and Monoclonal Reagents1
1987
Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assay
1994
Staphylococcal α toxin promotes blood coagulation via attack on human platelets
1988
Heparin‐associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides
1993
Analysis of granulocyte‐reactive antibodies using an immunoassay based upon monoclonal‐antibody‐specific immobilization of granulocyte antigens
1993
The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis
1993
Platelet-associated complement C3 in thrombocytopenic states
1983
The Bra/Brb alloantigen system on human platelets
1989
Monoclonal mouse antibodies to human MHC class I antigens cocap class II antigens
1984
Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies
1987
REDISTRIBUTION OF PLATELET GLYCOPROTEINS INDUCED BY ALLO- AND AUTOANTIBODIES
1987
Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific
1992
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA
1983
A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia
1991
Interrelations between Different Types of Cells
1968
Neonatal Alloimmune Thrombocytopenia due to Fetomaternal Zwb Incompatibility
1986
PRENATAL TREATMENT OF FETAL ALLOIMMUNE THROMBOCYTOPENIA
1988
Idiopathic Thrombocytopenic Purpura (ITP): Clinical and Immunologic Considerations
2008
Heparin-Associated Thrombocytopenia: The Effects of Various Intravenous lgG Preparations on Antibody Mediated Platelet Activation - A Possible New Indication for High Dose i.v. IgG
1994
HLA‐B7 on human red blood cells. Improved detection by a radioactive anti‐IgG test*
1982
Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells
1984
Endothelial Monocyte Antigens Are Coded for by Loci Centromeric of HLA‐B
1985
Characterization of the Structural Requirements for a Carbohydrate Based Anticoagulant with a Reduced Risk of Inducing the Immunological Type of Heparin-associated Thrombocytopenia
1995
Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies
1987
HLA and narcolepsy in a German population
1986